HeartForce is pleased to announce its latest multi-center study, to occur at the end of March 2021, in Uzbekistan. The research study will take place in coordination with three renowned heart centres, located in Tashkent and Karshi. The study will involve 1500 enrolled patients and will be supervised by the Eurasian Heart Foundation (EAHF), headquartered… Continue reading HeartForce to Commence CardioClin Multicenter Study in Uzbekistan
HeartForce is pleased to present a report of its latest studies and results for identifying patients with coronary artery disease (CAD) using seismocardiography (SCG). The findings of this study tested the performance of HeartForce SCG technology in identifying patients with CAD compared to other methods, including ECG stress test and coronary computed tomography angiography (CCTA).… Continue reading HeartForce CAD Report – Seismocardiography: A Reliable Screening Method to Detect Coronary Artery Disease
HeartForce received the 5th place prize out of 2648 companies from 118 countries at the K-Start Grand Challenge in South Korea. Minister Park Young-sun and the Ministry of SMEs and Startups (MSS), South Korea, presented the award to HeartForce at a special Gala Dinner in Seoul. The first five teams received government grants and were… Continue reading HeartForce Wins Award Over 2600 Companies at the K-Start Grand Challenge
Heart force attended the Computing in Cardiology Conference 2019, Singapore, Singapore and presented the results of study “Estimation of Cardiac Time Intervals from the Mechanical Activity of the Heart Using Machine Learning.”
To investigate the effects of the coronary artery disease on the morphology of the SCG and GCG waveforms, HeartForce designed and conducted an investigational study in the University Hospital Zürich, Switzerland. One hundred and fifty patients participated in this study, who were suspected of having coronary artery disease and were referred to the hospital for… Continue reading HeartForce Investigational Study – University Hospital of Zürich, Switzerland
To investigate the morphology of the SCG and GCG waveforms, Heart force designed and conducted an investigational study in Simon Fraser University in Vancouver, Canada. One hundred individuals in the 40-85 age range were recruited for this study.
HeartForce Medical Inc. held its annual general meeting on August 31, 2017, electing four new board members. Dr. Kouhyar Tavakolian, Dr. Geoff Houlton, Kay Jessel, and Dr. Erwin Bauer were all elected to the board. Beat Naegeli now serves as the chair and Jennie Choboter is Secretary. Kay Jessel was appointed by the newly-elected board… Continue reading New Board Members Appointed to HeartForce Medical’s Board of Directors
To investigate the estimation of cardiac time intervals in healthy young individuals using the SCG and GCG, Heart force designed and conducted an investigational study in Simon Fraser University in Vancouver, Canada. For this study, 120 individuals in the 18-40 age range were recruited.